CVS Financial Facts
Dividends declared per common share (in dollars per share): 0.13Net loss attributable to noncontrolling interest: 1M
See Full Income Statement
Other current assets: 502M
Accumulated other comprehensive loss: -152M
See Full Balance Sheet
CVS Caremark Corporation (CVS) Earnings
|
Expand Research on CVS
| Next EPS Date | N/A | EPS Growth Rate | N/A |
|---|---|---|---|
| Average EPS % Beat Rate | +13.8% | Revenue Growth Rate | N/A |
| Average % Move 1-Wk after EPS | -0.7% | Normal Earnings Time | Before Open |
| Date | Qtr | EPS | Cons. | Surprise | Revs | Cons. | Gd. | 1-Week % | 1-Day % | Details | |
|---|---|---|---|---|---|---|---|---|---|---|---|
| 8/3/22 | Q222 | N/A | $2.18 | N/A | N/A | $76.37B | N/A | N/A | N/A | ||
| 5/4/22 |  |
Q122 | $2.22 | $2.15 | +$0.07 | $76.8B | $75.39B | N/A |  | | Details |
| 2/9/22 | |
Q421 | $1.98 | $1.61 | +$0.37 | $76B | $74.89B | N/A | | | Details |
| 11/3/21 | |
Q321 | $1.97 | $1.77 | +$0.20 | $73.79B | $70.4B | N/A | | | Details |
| 8/4/21 | |
Q221 | $2.42 | $2.06 | +$0.36 | $72.6B | $70.11B | N/A | | | Details |
| 5/4/21 | |
Q121 | $2.04 | $1.71 | +$0.33 | $69.1B | $68.29B | N/A | | | Details |
| 2/16/21 | |
Q420 | $1.30 | $1.24 | +$0.06 | $69.55B | $68.73B | N/A | | | Details |
| 11/6/20 | |
Q320 | $1.66 | $1.33 | +$0.33 | $67.1B | $66.58B | N/A | | | Details |
